NVE CorpNVEC
Price$110.80Intrinsic value$38.7365% below price

Qualitative Analysis

Business overview

Business Overview

NVE Corporation (NASDAQ: NVEC) is a recognized leader in the practical commercialization of spintronics, a nanotechnology that utilizes electron spin rather than electron charge to acquire, store, and transmit information. Founded in 1989 by spintronics pioneer Dr. James M. Daughton, the Eden Prairie, Minnesota-based company designs and manufactures high-performance spintronic products, including sensors, couplers, and power integrated circuits (ICs). These products are highly valued for their extreme sensitivity, small size, high speed, low power consumption, and exceptional reliability. NVE's spintronic devices are widely deployed in demanding industrial, scientific, medical device (such as pacemakers and hearing aids), and military/aerospace applications.

Research as of 20 Jun 2026

Strategic Initiatives

Growth programs, investments, and their expected impact

AI-assisted
Wafer-Level Chip Scale Packaging (WLCSP) ExpansionInnovation

Developing and marketing new wafer-level chip-scale sensors to enable extreme miniaturization of implantable medical devices and surgical robots.

Expected impact: Enhances product precision and miniaturization, opening up high-value opportunities in medical devices, electric vehicles, and industrial automation.

Sign in / Sign up to read more
InvestmentPart of the capital expenditure allocated for advanced production equipment.
TimelineOngoing, with several new products launched in fiscal 2025 and 2026.
Production Capacity and Equipment ExpansionEfficiency

Installation and calibration of a several million dollar advanced equipment cluster in an expanded production area on the east end of the company's facility.

Expected impact: Increases manufacturing capacity, improves production yields, and supports the transition of R&D resources to manufacturing.

Sign in / Sign up to read more
Investment$1 million to $1.5 million in additional fixed asset spending.
TimelineCompleted installation and calibration in late fiscal 2026; now operational.

Mergers, Acquisitions & Partnerships

Recent deals and strategic collaborations

AI-assisted

Strategic Partnerships

Abbott Laboratories (Pacesetter subsidiary)Supplier Partnering Agreement

Abbott is a key customer in the implantable medical device sector. The agreement ensures long-term revenue stability and provides customized sensors for life-support medical devices.

Terms: Extended for two years through December 31, 2027, providing for price increases in calendar years 2026 and 2027.

Sign in / Sign up to read more
Sources: 1
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.